Author:
Sarrazin S.,Hein C.,Delrieu J.,Crestani S.,Menhour S.,Gilbert-Fontan E.,Van Kan Gabor Abellan
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology,Nutrition and Dietetics,Medicine (miscellaneous)
Reference10 articles.
1. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ECS guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37(38):2893–2962. https://doi.org/10.1093/eurheartj/ehw210
2. Pulipaka U, Lacomis D, Omalu B. Amiodarone-induced neuromyopathy: three cases and a review of the literature. J Clin Neuromuscul Dis. 2002 Mar; 3(3):97–105. https://doi.org/10.1097/00131402-200203000-00001
3. Agence Nationale de la Sécurité du Médicament et des produits de santé. Base de données publique des médicaments. Amiodarone — Résumé des caractéristiques du produit. 2020 update, http://base-donnees-publique.medicaments.gouv.fr
4. Pomponio G, Zurich MG, Schultz L, Weiss D, Romanelli L, Gramowski-Voss A et al. Amiodarone biokinetics, the formation of its major oxidative metabolite and neurotoxicity after acute and repeated exposure of brain cell cultures. Toxicology in vitro 2015; 30:192–202. https://doi.org/10.1016/j.tiv.2015.01.012
5. Hostetier KY, Giordano JR, Jellison EJ. In vitro inhibition of lysosomal phospholipase A, of rat lung by amiodarone and desethylamiodarone. BBA 1988; 959(3):316–321. https://doi.org/10.1016/0005-2760(88)90205-6
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献